China's Tsingke Biotechnology secures $57m in Series B round
The firm will use the proceeds to upgrade its technology platform as well as for team expansion.
Source: dealstreetasia.com
Stay updated with breaking news from Sharewin Capital. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
The firm will use the proceeds to upgrade its technology platform as well as for team expansion.
Online brokerage Webull has reportedly roped in investment bank Goldman Sachs to advise on its US share sale.